-
Experimental COVID-19 vaccine mRNA-1273 is safe and elicits response
europeanpharmaceuticalreview
July 16, 2020
Interim analysis of the Phase I trial data from 45 patients indicates mRNA-1273 can drive the production of antibodies targeting the SARS-CoV-2 spike protein.
-
Moderna expects to start late-stage COVID-19 vaccine trial on July 27
expresspharma
July 16, 2020
Moderna said it will conduct the trial at 87 study locations, all in the U.S.
-
Drug linked to 45% lower risk of dying among COVID-19 patients on ventilators
worldpharmanews
July 15, 2020
Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment ...
-
International regulators align positions on phase 3 COVID-19 vaccine trials
expresspharma
July 13, 2020
The meeting participants stressed the need for large phase 3 clinical trials that enroll many thousands of people, including those with underlying medical conditions, to generate relevant data for the key target populations.
-
Gilead says remdesivir reduced risk of death in Covid-19 patients, more studies needed
expresspharma
July 13, 2020
The company, which had initially released the data from the trial in April, said the finding requires confirmation in clinical trials.
-
Russian University completes clinical trials of world’s first COVID-19 vaccine
expresspharma
July 13, 2020
The clinical trials of COVID-19 vaccine produced by Gamalei Institute of Epidemiology and Microbiology started on June 18.
-
University of Oxford Selects Axiom eClinical Suite for Clinical Trial
contractpharma
July 08, 2020
Axiom Real-Time Metrics, a provider of unified eClinical solutions and services, has announced its engagement with the University of Oxford for its large-scale clinical trial focused on COVID-19 preventative treatments.
-
COVID-19 vaccine could be approved and available to public within six months: Poll
pharmaceutical-technology
July 03, 2020
The global spread of the COVID-19 pandemic and the resulting economic impact and public health burden has highlighted the urgent need for a vaccine to prevent the disease.
-
ICMR-Bharat Biotech to expedite clinical trials of COVID-19 vaccine, plan launch by August 15
expresspharma
July 03, 2020
Presently, 12 clinical trial sites have been identified and ICMR has asked the institutions to enable subject enrolment by the first week of July.
-
iBio Receives IBM Clinical Development Solution
contractpharma
July 02, 2020
Designed to support clinical COVID-19 vaccine candidates.